Medseven Healthcare

medsevendrugstore.com

“Our principle is to help our target market look and feel better in every aspect possible by building a healthy environment.” With presence over the course of four decades in United Arab Emirates, our board of directors at MEDSEVEN has excelled in Retail Pharmacy Industry. MEDSEVEN is a leading distribution company in UAE supplying Medical, Pharmaceutical and Generic and Cosmetic products over 135 target Retail Pharmacies in the industry. The company which is incorporated from seven pharmaceutical tycoons has its portfolio over 2500 products from Medical Supplies to imported generic items mostly from EU, North America, Australia and Asia. We’re in addition expanding and serving UAE market with our own product establishment known as Medseven One.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

LILLY BEGINS WORLD'S FIRST STUDY OF A POTENTIAL COVID-19 ANTIBODY TREATMENT IN HUMANS

Lilly | June 01, 2020

news image

Eli Lilly and Company (NYSE: LLY) today announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19. Lilly scientists rapidly developed the antibody in just three months after AbCellera and the Vaccine Research Center at t...

Read More

INTENT DATA IN THE AGE OF DATA REGULATION

DECK 7 | March 23, 2020

news image

Since the implementation of Data Protection Act in 2018, the approach behind the use of data has changed dramatically. Our clients and customers don’t just want a great experience, they also want to make sure they can trust us. Tweet This! And it makes perfect sense in the present time and space. But as data is considered a key factor in positive customer experience, the U.S. brands and agencies have found it to be increasingly complicated to earn customer trust while rem...

Read More

Medical

GENSCRIPT LAUNCHES GMP SINGLE-STRAND AND DOUBLE-STRAND DNA SERVICE FOR SUPPORTING GENE AND CELL THERAPY DEVELOPMENT

GenScript | May 18, 2022

news image

GenScript USA Inc., the world's leading life-science research tools and services provider, announced the availability of new GMP-grade GenExact™ single-stranded DNA (ssDNA) and GenWand™ closed-end linear double-stranded DNA (dsDNA) services. These services will enable next-generation gene and cell therapy R&D programs to advance to IND filing and clinical trials faster and more efficiently. Today's announcement, made at the American Society of Gene & Ce...

Read More

Industrial Impact, Medical

KYMANOX ANNOUNCES ACQUISITION OF ANTERIS MEDICAL AND ANTERIS HELVETIA

Kymanox | February 06, 2023

news image

Kymanox, a leading life science-focused professional services firm, recently announced the acquisition of anteris medical GmbH and anteris helvetia AG (collectively anteris). Anteris specializes in assisting the commercialization and development of medical equipment, combination and in-vitro diagnostic products. This acquisition enables both firms to achieve their common organizational goal of geographic expansion while enhancing their service capabilities by offering clients a ...

Read More
news image

LILLY BEGINS WORLD'S FIRST STUDY OF A POTENTIAL COVID-19 ANTIBODY TREATMENT IN HUMANS

Lilly | June 01, 2020

Eli Lilly and Company (NYSE: LLY) today announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19. Lilly scientists rapidly developed the antibody in just three months after AbCellera and the Vaccine Research Center at t...

Read More
news image

INTENT DATA IN THE AGE OF DATA REGULATION

DECK 7 | March 23, 2020

Since the implementation of Data Protection Act in 2018, the approach behind the use of data has changed dramatically. Our clients and customers don’t just want a great experience, they also want to make sure they can trust us. Tweet This! And it makes perfect sense in the present time and space. But as data is considered a key factor in positive customer experience, the U.S. brands and agencies have found it to be increasingly complicated to earn customer trust while rem...

Read More
news image

Medical

GENSCRIPT LAUNCHES GMP SINGLE-STRAND AND DOUBLE-STRAND DNA SERVICE FOR SUPPORTING GENE AND CELL THERAPY DEVELOPMENT

GenScript | May 18, 2022

GenScript USA Inc., the world's leading life-science research tools and services provider, announced the availability of new GMP-grade GenExact™ single-stranded DNA (ssDNA) and GenWand™ closed-end linear double-stranded DNA (dsDNA) services. These services will enable next-generation gene and cell therapy R&D programs to advance to IND filing and clinical trials faster and more efficiently. Today's announcement, made at the American Society of Gene & Ce...

Read More
news image

Industrial Impact, Medical

KYMANOX ANNOUNCES ACQUISITION OF ANTERIS MEDICAL AND ANTERIS HELVETIA

Kymanox | February 06, 2023

Kymanox, a leading life science-focused professional services firm, recently announced the acquisition of anteris medical GmbH and anteris helvetia AG (collectively anteris). Anteris specializes in assisting the commercialization and development of medical equipment, combination and in-vitro diagnostic products. This acquisition enables both firms to achieve their common organizational goal of geographic expansion while enhancing their service capabilities by offering clients a ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us